KURA logo

KURAKura Oncology Inc

$8.74
$0.03
(0.34%)
Today
Closed $8.74
$0.56
(6.41%)
After Hours
Updated: 07:58 PM EDT
Reported EarningsMay 12
Mkt Cap$775.89M
Vol3.23M

About

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
260

Frequently Asked Questions

What is Market Cap of Kura Oncology Inc?
What is the 52-week high for Kura Oncology Inc?
What is the 52-week low for Kura Oncology Inc?
What is Kura Oncology Inc stock price today?
What was Kura Oncology Inc stock price yesterday?
What is the PE ratio of Kura Oncology Inc?
What is the Price-to-Book ratio of Kura Oncology Inc?
What is the 50-day moving average of Kura Oncology Inc?
How many employees does Kura Oncology Inc have?

Advertisement|Remove ads.